Cassava Sciences Inc SAVA:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/23/22 EDT
27.23quote price arrow up+2.08 (+8.27%)
Volume
1,167,302
52 week range
15.72 - 146.16
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close27.23
  • 52 Week High146.16
  • 52 Week High Date07/29/21
  • 52 Week Low15.72
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap1.091B
  • Shares Out40.08M
  • 10 Day Average Volume1.27M
  • Dividend-
  • Dividend Yield-
  • Beta0.91
  • YTD % Change-37.69

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close27.23
  • 52 Week High146.16
  • 52 Week High Date07/29/21
  • 52 Week Low15.72
  • 52 Week Low Date05/12/22
  • Market Cap1.091B
  • Shares Out40.08M
  • 10 Day Average Volume1.27M
  • Dividend-
  • Dividend Yield-
  • Beta0.91
  • YTD % Change-37.69

RATIOS/PROFITABILITY

  • EPS (TTM)-1.16
  • P/E (TTM)-23.46
  • Fwd P/E (NTM)-15.40
  • EBITDA (TTM)-46.31M
  • ROE (TTM)-17.90%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/01/2022(est)
  • Ex Div Date12/13/2010
  • Div Amount2.00
  • Split Date-
  • Split Factor-

Latest On Cassava Sciences Inc

There is no recent news for this security.

Profile

MORE
Cassava Sciences, Inc. is a clinical-stage biotechnology company. The Company is focused on developing the drug for the treatment of neurodegenerative diseases, such as Alzheimer's disease. The Company’s products include Simufilam and SavaDx. Its lead therapeutic product candidate, Simufilam, is a proprietary small molecule (oral) drug. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer's brain. The SavaDx, is an early-stage program...
Remi Barbier
Chairman of the Board, President, Chief Executive Officer
Eric Schoen
Chief Financial Officer
Address
7801 N Capital of Texas Hwy Ste 260
Austin, TX
78731-1192
United States

Top Peers

SYMBOLLASTCHG%CHG
ZNTL
Zentalis Pharmaceuticals Inc
21.42-0.99-4.42%
LYEL
Lyell Immunopharma Inc
4.28+0.17+4.14%
CRNX
Crinetics Pharmaceuticals Inc
20.14-0.38-1.85%
TIL
Instil Bio Inc
7.82+0.55+7.57%
ALLO
Allogene Therapeutics Inc
7.46-0.02-0.27%